Neuroprotective actions of selective estrogen receptor modulators
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Summary Decreasing levels of sex hormones with aging may have a negative impact on brain function, since this decrease is associated with the progression of neurodegenerative disorders, increased depressive symptoms and other psychological disturbances. Extensive evidence from animal studies indicates that sex steroids, in particular estradiol, are neuroprotective. However, the potential benefits of estradiol therapy for the brain are counterbalanced by negative, life-threatening risks in the periphery. A potential therapeutic alternative to promote neuroprotection is the use of selective estrogen receptor modulators (SERMs), which may be designed to act with tissue selectivity as estrogen receptor agonists in the brain and not in other organs. Currently available SERMs act not only with tissue selectivity, but also with cellular selectivity within the brain and differentially modulate the activation of microglia, astroglia and neurons. Finally, SERMs may promote the interaction of estrogen receptors with the neuroprotective signaling of growth factors, such as the phosphatidylinositol 3-kinase/glycogen synthase kinase 3 pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302 · cited 2×
“In addition, GPR30 is a seven transmembrane domain protein that has been identified as a putative membrane estrogen receptor (Hewitt et al., 2005; Revankar et al., 2005), binds natural estrogens, SERMs and phytoestrogens and is present in the plasma membrane of hippocampal neurons (Funakoshi et…”
BackgroundShumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463 · cited 2×
“…with other transcription factors to stabilize binding of these transcription factors to specific response elements in the DNA and recruit specific co-activators or co-repressors that ultimately activate transcriptional machinery (Klinge, 2000; McKenna and O’Malley, 2002; Belandia and Parker, 2003).”
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Integration of the extranuclear and nuclear actions of estrogen
Levin, E. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0390 · Cited by 708
Extranuclear Steroid Receptors: Nature and Actions
Hammes, S. R., & Levin, E. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0022 · Cited by 475 · cited 2×
“Estrogenic compoundsmay also elicit rapid membrane and cytoplasmic actions by membrane-initiated steroid signaling (Kelly et al., 2005; Hammes and Levin, 2007; Kelly and Rønnekleiv, 2008; Vasudevan and Pfaff, 2008).”
BackgroundGao, Q., Mezei, G., Nie, Y., Rao, Y., Choi, C. S., Bechmann, I., Leranth, C., Toran-Allerand, D., Priest, C. A., Roberts, J. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1525 · Cited by 416 · cited 2×
“, 1999) and STAT3 (Ciana et al., 2003; Gao et al., 2007) and growth factors, such as brain-derived neurotrophic factor (BDNF) and insulin-like growth factor-I (IGF-I).”
BackgroundDistribution of Estrogen Receptor-β-Like Immunoreactivity in Rat Forebrain
Li, X., Schwartz, P. E., & Rissman, E. F. (2008) · Neuroendocrinology · doi:10.1159/000127221 · Cited by 257
Aromatase in the Brain: Not Just for Reproduction Anymore
Garcia‐Segura, L. M. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01713.x · Cited by 209 · cited 2×
“…upregulation of estrogen receptors in neurons (Dubal et al., 1999, 2006) and of the estradiol synthesizing enzyme aromatase in astrocytes (Garcia-Segura, 2008), these results suggest that estrogen receptor activation represents an endogenous protective mechanism that may be exploited…”
BackgroundFemale sex steroids: effects upon microglial cell activation
Drew, P. D., & Chavis, J. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00386-6 · Cited by 209 · cited 3×
“…and raloxifene, reduce microglia activation and the production of inflammatory mediators by microglia in response to various inflammatory stimuli and in animal models of Alzheimer’s disease (Drew and Chavis, 2000; Suuronen et al., 2005; Tapia-Gonzalez et al., 2008; Vegeto et al., 2006, 2008).”
Background
Cited by
Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733
“However, how SERMs can be estrogenic in some cells and antiestrogenic in others is not clearly understood (Cheskis et al., 2007; DonCarlos et al., 2009).”
BackgroundThe neuroprotective actions of oestradiol and oestrogen receptors
Arevalo, M.-A., Azcoitia, I., & Garcia-Segura, L. M. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3856 · Cited by 480
Self-citationRegulation of brain microglia by female gonadal steroids
Habib, P., & Beyer, C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.018 · Cited by 118
Mosquera, L., Colón, J. M., Santiago, J. M., Torrado, A. I., Meléndez, M., Segarra, A. C., Rodríguez-Orengo, J. F., & Miranda, J. D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.002 · Cited by 74
“…further stimulate the body's neuroprotective response after SCI. Neuroprotective effects of selective estrogen receptor modulators (SERMs) have also been reported (DonCarlos et al., 2009), without the complications that estradiol may generate, like the mitogenic effect on uterine and breast tissue.”
Buwalda, B., & Schagen, S. B. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.12.012 · Cited by 43
Metadata
- Authors
- DonCarlos, L. L., Azcoitia, I., & Garcia-Segura, L. M.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 34
- Pages
- S113-S122
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2065632340
- Cited by
- 86
- References
- 12
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotective actions of selective estrogen receptor modulators. https://app.cochat.ai/papers/10.1016/j.psyneuen.2009.04.012
- The paper
- DonCarlos, L. L., Azcoitia, I., & Garcia-Segura, L. M. (2009). Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2009.04.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.